127 related articles for article (PubMed ID: 38546708)
1. 5-Aminothiazoles Reveal a New Ligand-Binding Site on Prolyl Oligopeptidase Which is Important for Modulation of Its Protein-Protein Interaction-Derived Functions.
Pätsi HT; Kilpeläinen TP; Jumppanen M; Uhari-Väänänen J; Wielendaele PV; De Lorenzo F; Cui H; Auno S; Saharinen J; Seppälä E; Sipari N; Savinainen J; De Meester I; Lambeir AM; Lahtela-Kakkonen M; Myöhänen TT; Wallén EAA
J Med Chem; 2024 Apr; 67(7):5421-5436. PubMed ID: 38546708
[TBL] [Abstract][Full Text] [Related]
2. The effect of prolyl oligopeptidase inhibitors on alpha-synuclein aggregation and autophagy cannot be predicted by their inhibitory efficacy.
Kilpeläinen TP; Hellinen L; Vrijdag J; Yan X; Svarcbahs R; Vellonen KS; Lambeir AM; Huttunen H; Urtti A; Wallen EAA; Myöhänen TT
Biomed Pharmacother; 2020 Aug; 128():110253. PubMed ID: 32447211
[TBL] [Abstract][Full Text] [Related]
3. Nonpeptidic Oxazole-Based Prolyl Oligopeptidase Ligands with Disease-Modifying Effects on α-Synuclein Mouse Models of Parkinson's Disease.
Kilpeläinen TP; Pätsi HT; Svarcbahs R; Julku UH; Eteläinen TS; Cui H; Auno S; Sipari N; Norrbacka S; Leino TO; Jäntti M; Myöhänen TT; Wallén EAA
J Med Chem; 2023 Jun; 66(11):7475-7496. PubMed ID: 37248563
[TBL] [Abstract][Full Text] [Related]
4. Study of the Conformational Dynamics of Prolyl Oligopeptidase by Mass Spectrometry: Lessons Learned.
Van Elzen R; Konijnenberg A; Van der Veken P; Edgeworth MJ; Scrivens JH; Fülöp V; Sobott F; Lambeir AM
J Med Chem; 2024 Jun; 67(12):10436-10446. PubMed ID: 38783480
[TBL] [Abstract][Full Text] [Related]
5. Prolyl oligopeptidase enhances α-synuclein dimerization via direct protein-protein interaction.
Savolainen MH; Yan X; Myöhänen TT; Huttunen HJ
J Biol Chem; 2015 Feb; 290(8):5117-5126. PubMed ID: 25555914
[TBL] [Abstract][Full Text] [Related]
6. The beneficial effect of a prolyl oligopeptidase inhibitor, KYP-2047, on alpha-synuclein clearance and autophagy in A30P transgenic mouse.
Savolainen MH; Richie CT; Harvey BK; Männistö PT; Maguire-Zeiss KA; Myöhänen TT
Neurobiol Dis; 2014 Aug; 68():1-15. PubMed ID: 24746855
[TBL] [Abstract][Full Text] [Related]
7. Distribution of prolyl oligopeptidase in human peripheral tissues and in ovarian and colorectal tumors.
Myöhänen TT; Pyykkö E; Männistö PT; Carpen O
J Histochem Cytochem; 2012 Sep; 60(9):706-15. PubMed ID: 22740343
[TBL] [Abstract][Full Text] [Related]
8. Inhibition-mediated changes in prolyl oligopeptidase dynamics possibly related to α-synuclein aggregation.
Walczewska-Szewc K; Rydzewski J; Lewkowicz A
Phys Chem Chem Phys; 2022 Feb; 24(7):4366-4373. PubMed ID: 35112120
[TBL] [Abstract][Full Text] [Related]
9. Prolyl Oligopeptidase Regulates Dopamine Transporter Oligomerization and Phosphorylation in a PKC- and ERK-Independent Manner.
Julku UH; Jäntti M; Svarcbahs R; Myöhänen TT
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33579026
[TBL] [Abstract][Full Text] [Related]
10. Different interactions of prolyl oligopeptidase and neurotensin in dopaminergic function of the rat nigrostriatal and mesolimbic pathways.
Peltonen I; Myöhänen TT; Männistö PT
Neurochem Res; 2012 Sep; 37(9):2033-41. PubMed ID: 22729983
[TBL] [Abstract][Full Text] [Related]
11. Structural analysis of prolyl oligopeptidases using molecular docking and dynamics: insights into conformational changes and ligand binding.
Kaushik S; Sowdhamini R
PLoS One; 2011; 6(11):e26251. PubMed ID: 22132071
[TBL] [Abstract][Full Text] [Related]
12. Prolyl oligopeptidase inhibition reduces oxidative stress via reducing NADPH oxidase activity by activating protein phosphatase 2A.
Eteläinen T; Kulmala V; Svarcbahs R; Jäntti M; Myöhänen TT
Free Radic Biol Med; 2021 Jun; 169():14-23. PubMed ID: 33838285
[TBL] [Abstract][Full Text] [Related]
13. 2-Imidazole as a Substitute for the Electrophilic Group Gives Highly Potent Prolyl Oligopeptidase Inhibitors.
Pätsi HT; Kilpeläinen TP; Auno S; Dillemuth PMJ; Arja K; Lahtela-Kakkonen MK; Myöhänen TT; Wallén EAA
ACS Med Chem Lett; 2021 Oct; 12(10):1578-1584. PubMed ID: 34671446
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Prolyl Oligopeptidase Restores Spontaneous Motor Behavior in the α-Synuclein Virus Vector-Based Parkinson's Disease Mouse Model by Decreasing α-Synuclein Oligomeric Species in Mouse Brain.
Svarcbahs R; Julku UH; Myöhänen TT
J Neurosci; 2016 Dec; 36(49):12485-12497. PubMed ID: 27927963
[TBL] [Abstract][Full Text] [Related]
15. Identification of selective and potent inhibitors of fibroblast activation protein and prolyl oligopeptidase.
Poplawski SE; Lai JH; Li Y; Jin Z; Liu Y; Wu W; Wu Y; Zhou Y; Sudmeier JL; Sanford DG; Bachovchin WW
J Med Chem; 2013 May; 56(9):3467-77. PubMed ID: 23594271
[TBL] [Abstract][Full Text] [Related]
16. Novel benzimidazole derivatives as effective inhibitors of prolyl oligopeptidase: synthesis,
Shakoor A; Alam A; Jan F; Khan M; Ali M; Ullah S; Khan A; AlAsmari AF; Alasmari F; Al-Ghafri A; Al-Harrasi A
Future Med Chem; 2024 Jan; 16(1):43-58. PubMed ID: 38054466
[No Abstract] [Full Text] [Related]
17. Molecular dynamics, crystallography and mutagenesis studies on the substrate gating mechanism of prolyl oligopeptidase.
Kaszuba K; Róg T; Danne R; Canning P; Fülöp V; Juhász T; Szeltner Z; St Pierre JF; García-Horsman A; Männistö PT; Karttunen M; Hokkanen J; Bunker A
Biochimie; 2012 Jun; 94(6):1398-411. PubMed ID: 22484394
[TBL] [Abstract][Full Text] [Related]
18. Prolyl oligopeptidase inhibition activates autophagy via protein phosphatase 2A.
Svarcbahs R; Jäntti M; Kilpeläinen T; Julku UH; Urvas L; Kivioja S; Norrbacka S; Myöhänen TT
Pharmacol Res; 2020 Jan; 151():104558. PubMed ID: 31759088
[TBL] [Abstract][Full Text] [Related]
19. Removal of prolyl oligopeptidase reduces alpha-synuclein toxicity in cells and in vivo.
Svarcbahs R; Julku UH; Norrbacka S; Myöhänen TT
Sci Rep; 2018 Jan; 8(1):1552. PubMed ID: 29367610
[TBL] [Abstract][Full Text] [Related]
20. New tricks of prolyl oligopeptidase inhibitors - A common drug therapy for several neurodegenerative diseases.
Svarcbahs R; Julku U; Kilpeläinen T; Kyyrö M; Jäntti M; Myöhänen TT
Biochem Pharmacol; 2019 Mar; 161():113-120. PubMed ID: 30660495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
